All these data are consistent with our working model in Figure 7h showing that the widespread UHRF1/2 overexpression leads to excessive degradation of DNMT3A proteins in cancers, which in turn leads to widespread hypomethylation in cancers. The gene discussed is DNMT3A; the disease is cancer.